Pharmaceutical Microfiltration Market worth $9.94 billion by 2030 | MarketsandMarkets™

According to MarketsandMarkets™, the Pharmaceutical Microfiltration Market is projected to grow from about USD 6.13 billion ...

Data Center Access Control Market worth $2.53 billion by 2030 - Exclusive Report by MarketsandMarkets™

According to MarketsandMarkets™, the data center access control market is expected to grow from USD 1.55 billion in 2025 to ...

Pharmaceutical Microfiltration Market worth $9.94 billion by 2030 | MarketsandMarkets

According to MarketsandMarkets, the Pharmaceutical Microfiltration Market is projected to grow from about USD 6.13 billion in 2025 to USD 9.94 ...

Services NDT and Inspection Market worth $17.31 billion by 2030 - Exclusive Report by MarketsandMarkets

According to MarketsandMarkets, the services NDT and inspection market is expected to grow from USD 11.41 billion in 2025 to USD 17.31 billion ...
Kauppalehti

United Bankers Plc’s share repurchase program announced in March 2025 has been completed

United Bankers Plc has completed its share repurchase program, which was announced in March 2025. Between 24 March 2025 – 8 January 2026, United Bankers repurchased a total of 50,000 own shares at an ...
Midland Daily News on MSN

Savvy Senior: How to choose a good nursing home for your loved one

Choosing a nursing home for a loved one that provides quality is a very important decision that requires careful evaluation ...

Industrial Gases Market worth $126,526.8 million by 2030 at 5.1%, says MarketsandMarkets™

In terms of value, the Industrial Gases Market projected to be worth USD 126,526.8 million by 2030, registering a CAGR of 5.1 ...

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera® (zanidatamab-hrii) in combination with ...
Fierce Biotech

AbbVie, Gilead gift themselves clinical-stage cancer drugs via licensing deals

AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. | ...
The Heartland InstituteOpinion

Research & Commentary: Magnolia Student Accounts Would Be a Boon to Mississippi Families

Legislation introduced in the Mississippi House of Representatives would set up “Magnolia Student Accounts” (MSA), an ...
Heart

Prehospital risk stratification in suspected non-ST-segment elevation acute coronary syndrome with point-of-care troponin: an individual patient data meta-analysis

Background Emergency Medical Services (EMS) patients with chest pain are often suspected of having non-ST-elevation acute coronary syndrome (NSTE-ACS). Current risk stratification protocols for ...